Stockreport

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results [Yahoo! Finance]

Cytek Biosciences, Inc.  (CTKB) 
PDF FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unaud [Read more]